diltiazem has been researched along with thromboxane a2 in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (41.67) | 18.7374 |
1990's | 13 (54.17) | 18.2507 |
2000's | 1 (4.17) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haught, WH; Lawson, DL; Mehta, JL; Yang, BC | 1 |
Abbate, R; Boddi, M; Coppo, M; Gensini, GF; Neri Serneri, GG; Prisco, D; Rostagno, C | 1 |
Feng, HF; Zhang, YH; Zhao, X | 1 |
Buja, LM; Golino, P; McNatt, J; Willerson, JT; Yao, SK | 1 |
Furui, H; Furumichi, T; Hayashi, H; Saito, H; Suzuki, T; Yamada, Y; Yamauchi, K; Yokota, M | 1 |
Abbate, R; Boddi, M; Costanzo, G; Paniccia, R; Poggesi, L; Prisco, D; Rostagno, C | 1 |
Francis, GS; Johnson, GJ; Leis, LA | 1 |
Brunelli, C; Caponnetto, S; Galassi, AR; Hackett, D; Ianetti, M; Lipkin, D; Maseri, A; Patrono, C; Spallarossa, P; Vejar, M | 1 |
Kito, M; Matsuura, T; Moriyama, T; Narita, H; Takamura, H; Tanaka, K | 1 |
Hall, ED; Wolf, DL | 1 |
Fulmor, IE; Grover, GJ | 1 |
Corrigan, JJ; Fenster, PE; Ring, ME | 2 |
Mehta, J; Mehta, P; Ostrowski, N | 1 |
Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y | 1 |
Miwa, K; Toda, N | 1 |
Honn, KV; Onoda, JM; Sloane, BF | 1 |
Brigmon, L; Mehta, J; Mehta, P; Ostrowski, N | 1 |
Kalsner, S | 1 |
Hosoki, K; Karasawa, T; Kikuta, C; Yamamoto, T | 1 |
Epstein, M; Hayashi, K; Loutzenhiser, R | 1 |
Afzal, MN; Saeed, SA; Shah, BH | 1 |
Cartier, R; Demers, P; Elkouri, S; Mathieu, P | 1 |
Hanif, S; Khan, FL; Rahman, HB; Rahman, IH; Rasheed, H; Saeed, SA; Shah, BH; Shariff, AH | 1 |
4 trial(s) available for diltiazem and thromboxane a2
Article | Year |
---|---|
[Drug modulation of thromboxane A2/prostacyclin balance and lipid peroxidation in patients with coronary artery disease].
Topics: Aged; Aspirin; Coronary Disease; Diltiazem; Epoprostenol; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Superoxide Dismutase; Thromboxane A2 | 1990 |
Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Aggregation; Thromboxane A2; Verapamil | 1990 |
Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Diltiazem; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Platelet Aggregation; Randomized Controlled Trials as Topic; Thromboxane A2; Thromboxane B2 | 1990 |
Antiplatelet effects of oral diltiazem, propranolol, and their combination.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Diltiazem; Drug Interactions; Epinephrine; Humans; Male; Platelet Aggregation Inhibitors; Propranolol; Thromboxane A2 | 1987 |
20 other study(ies) available for diltiazem and thromboxane a2
Article | Year |
---|---|
Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Aorta; Diltiazem; In Vitro Techniques; Indomethacin; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxygen; Oxyhemoglobins; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Thromboxane A2; Vasoconstriction; Verapamil | 1992 |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Diltiazem; Female; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Nitrendipine; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Verapamil | 1991 |
Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo.
Topics: Animals; Blood Platelets; Coronary Disease; Coronary Vessels; Diltiazem; Dogs; Endothelium, Vascular; Hemodynamics; Nitroglycerin; Platelet Aggregation; Serotonin; Thromboxane A2; Vasoconstriction | 1990 |
Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Aspirin; Blood Platelets; Bone Marrow Cells; Calcium Channel Blockers; Collagen; Diltiazem; Endothelium, Vascular; Epoprostenol; Fibroblasts; Humans; Nicardipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thromboxane A2; Verapamil | 1990 |
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Topics: Adenosine; Alprostadil; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Verapamil | 1990 |
Dihydropyridine-sensitive and insensitive Ca2+ channels in human platelets.
Topics: Blood Platelets; Calcium Channels; Collagen; Diltiazem; Humans; In Vitro Techniques; Nifedipine; Thromboxane A2 | 1988 |
A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.
Topics: Animals; Benzofurans; Calcium Channel Blockers; Cats; Cyclooxygenase Inhibitors; Diltiazem; Dinoprost; Epoprostenol; Female; Ibuprofen; Ischemia; Male; Meclofenamic Acid; Nifedipine; Prostaglandin Antagonists; Prostaglandins F; Spinal Cord; Thromboxane A2; Verapamil; Vitamin E | 1986 |
Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatment.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Coronary Circulation; Diltiazem; Dogs; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Myocardial Contraction; Perfusion; Thromboxane A2; Time Factors | 1988 |
Calcium blocker diltiazem inhibits platelet activation and stimulates vascular prostacyclin synthesis.
Topics: Benzazepines; Blood Platelets; Diltiazem; Epoprostenol; Humans; Platelet Aggregation; Thromboxane A2; Umbilical Veins | 1986 |
Thromboxane A2 analogue induced coronary artery vasoconstriction in the rabbit.
Topics: Animals; Calcium; Coronary Angiography; Coronary Vasospasm; Diltiazem; Dose-Response Relationship, Drug; Rabbits; Thromboxane A2 | 1987 |
Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Administration, Oral; Aspirin; Bleeding Time; Blood Platelets; Diltiazem; Epinephrine; Humans; Male; Platelet Aggregation; Thromboxane A2 | 1986 |
The regional difference of relaxations induced by various vasodilators in isolated dog coronary and mesenteric arteries.
Topics: Adenosine; Alprostadil; Animals; Coronary Vessels; Diltiazem; Dogs; Epoprostenol; Female; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Thromboxane A2; Vasodilator Agents | 1985 |
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Topics: Adenosine Diphosphate; Benzofurans; Blood Platelets; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epoprostenol; Humans; Nicotinic Acids; Nifedipine; Nimodipine; Oxidoreductases; Platelet Aggregation; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Verapamil | 1984 |
Inhibitory effects of diltiazem on platelet activation caused by ionophore A23187 plus ADP or epinephrine in subthreshold concentrations.
Topics: Adenosine Diphosphate; Adult; Benzazepines; Calcimycin; Calcium Chloride; Diltiazem; Epinephrine; Epoprostenol; Humans; Platelet Aggregation; Thromboxane A2; Thromboxane B2 | 1983 |
Non-neurogenic contractions in isolated coronary arteries by brief electrical pulses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Cattle; Coronary Vessels; Diltiazem; Electric Stimulation; In Vitro Techniques; Insecticides; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Pyrethrins; Ryanodine; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Calcium Channel Blockers; Dibenzothiepins; Diltiazem; Electrocardiography; Heart Rate; Male; Myocardial Ischemia; Myocardium; Oxygen Consumption; Piperazines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Kidney Glomerulus; Male; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction | 1997 |
Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
Topics: Blood Platelets; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Humans; Nitric Oxide Donors; Penicillamine; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Verapamil | 1998 |
[The vasoconstrictor effect of cyclosporine on the pulmonary vein is mediated by its vehicle: the cremophor].
Topics: Animals; Bicyclic Monoterpenes; Calcium Channel Blockers; Calcium Channels; Cyclooxygenase Inhibitors; Cyclosporine; Diltiazem; Dogs; Immunosuppressive Agents; Indomethacin; Isometric Contraction; Muscle, Smooth, Vascular; Pharmaceutical Vehicles; Polyethylene Glycols; Pulmonary Veins; Thromboxane A2; Vasoconstriction; Vasodilator Agents | 1998 |
Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Topics: Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Estrenes; Flavonoids; Humans; In Vitro Techniques; Indomethacin; Kinetics; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Pyrrolidinones; Serotonin; Thromboxane A2; Verapamil | 2001 |